Lynparza: Regulatory decision in EU for 1L ovarian cancer (based on PAOLA trial) in H2 2020 (AstraZeneca) - Aug 21, 2020 - Post H1 Roadshow, Oslo: Regulatory decision in EU for 2L prostate cancer in H2 2020
European regulatory • Oncology • Ovarian Cancer • Prostate Cancer
|